Scilex Holding (SCLX) Gross Profit (2022 - 2026)
Scilex Holding (SCLX) recorded quarterly Gross Profit of $4.2 million in Q1 2026, up 86.57% quarter-over-quarter from $2.2 million in Q4 2025, and up 14.85% on a YoY basis from $3.6 million in Q1 2025.
Scilex Holding (SCLX) Gross Profit (2022 - 2026) Analysis & Trends
Scilex Holding's Gross Profit history runs 5 years deep, the most recent figure standing at $4.2 million for Q1 2026.
- In Q1 2026, Gross Profit rose 14.85% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $20.2 million (down 44.52% YoY), while the FY2025 annual figure was $19.7 million, down 50.63% from the prior year.
- Gross Profit was $4.2 million for Q1 2026 at Scilex Holding, up from $2.2 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $12.0 million in Q2 2024 to a low of $2.2 million in Q4 2025.
- Historically, Gross Profit has averaged $7.2 million across 5 years, with a median of $7.0 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Gross Profit soared 58.63% in 2024, then sank 78.2% in 2025.
- A 5-year view of Gross Profit shows it stood at $7.4 million in 2022, then gained by 20.73% to $8.9 million in 2023, then climbed by 14.18% to $10.2 million in 2024, then tumbled by 78.2% to $2.2 million in 2025, then jumped by 86.57% to $4.2 million in 2026.
- The last three Gross Profit figures came in at $4.2 million (Q1 2026), $2.2 million (Q4 2025), and $7.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn |
| 10 | Scilex Holding | 48.31 Mn | -101.62 Mn | 4.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.15 Mn |
| Mar 31, 2026 | 4.15 Mn |
| Dec 31, 2025 | 2.23 Mn |
| Dec 31, 2025 | 2.23 Mn |
| Sep 30, 2025 | 7.23 Mn |
| Sep 30, 2025 | 7.23 Mn |
| Jun 30, 2025 | 6.62 Mn |
| Jun 30, 2025 | 6.62 Mn |
| Mar 31, 2025 | 3.62 Mn |
| Mar 31, 2025 | 3.62 Mn |
| Dec 31, 2024 | 10.21 Mn |
| Dec 31, 2024 | 10.21 Mn |
| Sep 30, 2024 | 10.67 Mn |
| Sep 30, 2024 | 10.67 Mn |
| Jun 30, 2024 | 11.98 Mn |
| Jun 30, 2024 | 11.98 Mn |
| Mar 31, 2024 | 7.04 Mn |
| Mar 31, 2024 | 7.04 Mn |
| Dec 31, 2023 | 8.94 Mn |
| Dec 31, 2023 | 8.94 Mn |